Publication Information

{'id': 'https://openalex.org/W2013813167', 'doi': 'https://doi.org/10.1158/1535-7163.targ-13-c89', 'title': 'Abstract C89: Galeterone suppresses castration-resistant and enzalutamide-resistant prostate cancer growth in vitro.', 'display_name': 'Abstract C89: Galeterone suppresses castration-resistant and enzalutamide-resistant prostate cancer growth in vitro.', 'publication_year': 2013, 'publication_date': '2013-11-01', 'ids': {'openalex': 'https://openalex.org/W2013813167', 'doi': 'https://doi.org/10.1158/1535-7163.targ-13-c89', 'mag': '2013813167'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-13-c89', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5088300469', 'display_name': 'Nader Al Nakouzi', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Nader Al Nakouzi', 'raw_affiliation_strings': ['1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044476010', 'display_name': 'Chris Wang', 'orcid': 'https://orcid.org/0000-0001-6784-2139'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Chris Wang', 'raw_affiliation_strings': ['1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049675654', 'display_name': 'David B. Jacoby', 'orcid': 'https://orcid.org/0000-0003-2195-9512'}, 'institutions': [{'id': 'https://openalex.org/I4210129771', 'display_name': 'Tokai Pharmaceuticals (United States)', 'ror': 'https://ror.org/03nvr8032', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210129771']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Douglas Jacoby', 'raw_affiliation_strings': ['2Tokai Pharmaceuticals, Cambridge, MA'], 'affiliations': [{'raw_affiliation_string': '2Tokai Pharmaceuticals, Cambridge, MA', 'institution_ids': ['https://openalex.org/I4210129771']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062125605', 'display_name': 'Martin Gleave', 'orcid': 'https://orcid.org/0000-0003-4235-0167'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Martin E. Gleave', 'raw_affiliation_strings': ['1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Centre/UBC, Vancouver, British Columbia, Canada', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.738, 'has_fulltext': False, 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.71777, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 80, 'max': 81}, 'biblio': {'volume': '12', 'issue': '11_Supplement', 'first_page': 'C89', 'last_page': 'C89'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10756', 'display_name': 'Estrogen and related hormone effects', 'score': 0.9242, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.918, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.99520737}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.99520737}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.8359961}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.82732606}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.7565243}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.58187467}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.56847805}, {'id': 'https://openalex.org/C2777911890', 'wikidata': 'https://www.wikidata.org/wiki/Q62614', 'display_name': 'Androgen', 'level': 3, 'score': 0.5156921}, {'id': 'https://openalex.org/C2777899217', 'wikidata': 'https://www.wikidata.org/wiki/Q4759439', 'display_name': 'Androgen deprivation therapy', 'level': 4, 'score': 0.48993248}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46979058}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42773402}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3569476}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.09062141}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-13-c89', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.54, 'id': 'https://metadata.un.org/sdg/9', 'display_name': 'Industry, innovation and infrastructure'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4282974758', 'https://openalex.org/W3087152049', 'https://openalex.org/W2954196387', 'https://openalex.org/W2948523439', 'https://openalex.org/W2740124347', 'https://openalex.org/W2739481929', 'https://openalex.org/W2503901337', 'https://openalex.org/W2157750797', 'https://openalex.org/W1528618484', 'https://openalex.org/W1511886058'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Despite': [2, 80], 'the': [3, 15, 31, 53, 81, 105, 147, 165, 228, 237, 295, 367, 373, 425], 'progress': [4], 'and': [5, 9, 35, 48, 96, 155, 189, 223, 230, 244, 260, 288, 294, 337, 370, 414, 431], 'innovation': [6], 'in': [7, 30, 160, 175, 213, 236, 254, 257, 263, 277, 286, 301, 311, 318, 349, 419], 'chemo-': [8], 'immunotherapies,': [10], 'androgen': [11, 45, 144, 153], 'deprivation': [12], 'therapy': [13, 91, 378], 'remains': [14, 56], 'standard': [16], 'treatment': [17, 102], 'of': [18, 33, 39, 65, 98, 133, 141, 167, 184, 198, 221, 234, 297, 366, 376, 424], 'metastatic': [19], 'prostate': [20, 416], 'cancer.': [21], 'However,': [22], 'progression': [23], 'to': [24, 43, 89, 135, 151, 171, 218, 226, 266, 269], 'castrate': [25], 'resistance': [26, 88], 'disease': [27], '(CRPC)': [28], 'occurs': [29], 'majority': [32], 'patients': [34, 380], 'intriguingly,': [36], 'over': [37], '80%': [38], 'CRPC': [40, 190, 258, 384], 'specimens': [41], 'continue': [42], 'express': [44], 'receptor': [46], '(AR)': [47, 281], 'androgen-responsive': [49], 'genes,': [50], 'indicating': [51], 'that': [52, 110, 118, 129, 249, 331, 360], 'AR': [54, 77, 99, 137, 157, 173, 231, 287, 298, 319, 335, 368], 'axis': [55], 'paradoxically': [57], 'activated': [58], 'despite': [59], 'castration.': [60], 'Hence,': [61], 'several': [62], 'new': [63, 116], 'classes': [64], 'AR-targeting': [66], 'agents': [67], 'have': [68], 'been': [69, 94], 'recently': [70], 'introduced': [71], 'into': [72], 'clinic,': [73], 'including': [74], 'more': [75], 'potent': [76, 364], 'antagonists': [78], '(enzalutamide).': [79], 'substantial': [82], 'clinical': [83, 108], 'efficacy': [84, 166], 'reported': [85], 'with': [86, 381], 'Enzalutamide,': [87], 'this': [90, 161, 168, 353], 'has': [92], 'already': [93], 'observed': [95, 310], 'reactivation': [97], 'signaling': [100], 'following': [101], 'occurs.': [103], 'Thus,': [104, 159], 'next': [106, 374], 'major': [107], 'challenge': [109], 'we': [111, 163, 247, 355], 'will': [112], 'face': [113], 'is': [114, 125, 362], 'identifying': [115], 'therapies': [117], 'prevent': [119, 152], 'or': [120, 203, 321], 'treat': [121], 'anti-androgen': [122], 'resistance.': [123], 'Galeterone': [124, 361, 411], 'a': [126, 181, 274, 283, 357, 363], 'novel': [127], 'drug': [128, 170, 187], 'exhibits': [130], 'three': [131, 196], 'mechanisms': [132], 'action': [134], 'inhibit': [136, 172], 'activity,': [138, 282], 'via': [139], 'inhibition': [140, 296], 'de': [142], 'novo': [143], 'synthesis,': [145], 'blocking': [146], 'ligand': [148], 'binding': [149], 'domain': [150], 'binding,': [154], 'inducing': [156], 'degradation.': [158], 'study': [162, 227], 'evaluated': [164], 'multi-potent': [169], 'activity': [174, 336], 'enzalutamide': [176, 185, 201, 222, 238, 270, 345], 'resistant': [177, 188, 239, 265, 312, 388], 'cells.': [178], 'Results:': [179], 'As': [180], 'pre-clinical': [182], 'model': [183], 'resistance,': [186], 'cell': [191, 303, 347], 'lines': [192], 'were': [193, 211, 224, 308], 'derived': [194], 'from': [195], 'generations': [197], 'serially': [199], 'passaged': [200], 'resistant,': [202], 'vehicle': [204], 'control': [205], 'treated,': [206], 'LNCaP': [207, 255, 340], 'xenografts.': [208], 'Resistant': [209], 'cells': [210], 'maintained': [212], 'vitro': [214], 'under': [215], 'constant': [216], 'exposure': [217], '10': [219], 'μM': [220], 'used': [225], 'anti-cancer': [229], 'targeting': [232], 'effects': [233, 253, 307], 'galeterone': [235, 250, 272, 332], 'setting.': [240], 'Using': [241], 'crystal': [242], 'violet': [243], 'MTT': [245], 'assays,': [246], 'found': [248], 'had': [251], 'anti-proliferative': [252], 'cells,': [256, 259, 313], 'most': [261], 'importantly,': [262], 'those': [264], 'enzalutamide.': [267], 'Compared': [268], 'treatment,': [271], 'induced': [273], 'drastic': [275], 'decrease': [276, 317], 'Probasin': [278], 'luciferase': [279], 'reporter': [280], 'greater': [284], 'reduction': [285], 'prostate-specific': [289], 'antigen': [290], '(PSA)': [291], 'protein': [292], 'expression,': [293], 'nuclear': [299, 322], 'translocation': [300, 323], 'all': [302], 'lines.': [304], 'Strikingly,': [305], 'these': [306], 'still': [309], 'which': [314], 'show': [315, 330], 'no': [316], 'expression': [320], 'upon': [324], 'enzalutmide': [325], 'treatment.': [326], 'Together,': [327], 'our': [328], 'data': [329], 'strongly': [333], 'inhibits': [334], 'suppresses': [338, 412], 'castration-resistant': [339, 413], 'growth': [341, 348, 418], 'as': [342, 344], 'well': [343], '-resistant': [346], 'vitro.': [350, 420], 'Conclusion:': [351], 'In': [352], 'study,': [354], 'provide': [356], 'preclinical': [358], 'proof-of-principle': [359], 'inhibitor': [365], 'pathway': [369], 'may': [371], 'represent': [372], 'generation': [375], 'hormone': [377], 'for': [379], 'not': [382], 'only': [383], 'but': [385], 'also': [386], 'Enzalutamide': [387], 'disease.': [389], 'Citation': [390, 397], 'Information:': [391], 'Mol': [392, 442], 'Cancer': [393, 432, 443], 'Ther': [394, 444], '2013;12(11': [395, 445], 'Suppl):C89.': [396], 'Format:': [398], 'Nader': [399], 'Al': [400], 'Nakouzi,': [401], 'Chris': [402], 'Wang,': [403], 'Douglas': [404], 'Jacoby,': [405], 'Martin': [406], 'E.': [407], 'Gleave,': [408], 'Amina': [409], 'Zoubeidi.': [410], 'enzalutamide-resistant': [415], 'cancer': [417], '[abstract].': [421], 'In:': [422], 'Proceedings': [423], 'AACR-NCI-EORTC': [426], 'International': [427], 'Conference:': [428], 'Molecular': [429], 'Targets': [430], 'Therapeutics;': [433], '2013': [434], 'Oct': [435], '19-23;': [436], 'Boston,': [437], 'MA.': [438], 'Philadelphia': [439], '(PA):': [440], 'AACR;': [441], 'Suppl):Abstract': [446], 'nr': [447], 'C89.': [448]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2013813167', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}], 'updated_date': '2024-12-14T22:14:41.821891', 'created_date': '2016-06-24'}